Friday, February 26, 2021

Israel data shows Pfizer jab stops illness, effect on transmissions unclear

Israel is carrying out what is widely described as the world's fastest vaccination campaign per capita, watched closely by experts worldwide.

Other News

Palm oil churns trouble in Canadian ‘hard butter’ puzzle

The pandemic has increased demand for butter, so farmers are feeding extra palm oil derivatives to their cows to produce more milk fat.

Kes positif Covid-19 meningkat lebih 2,000 semula

11 lagi kematian dicatatkan menjadikan jumlah 1,111 kes.

Daily cases back over 2,000, death toll up by 11

2,253 new cases, 3,085 recoveries.

Glove giant Top Glove applies for Hong Kong listing

Top Glove hopes the listing will enable it to raise capital for its global business growth, as well as worldwide expansion and strategic investments.

Projek lebuh raya kontroversi diteruskan walaupun bantahan meningkat?

Pengkritik mengatakan projek PJD Link hampir menyerupai pojek Kidex yang dibatalkan kerana bantahan kuat pada 2015.

Initial data from Israel’s coronavirus vaccination campaign shows the Pfizer/BioNTech jab protects against serious illness, but it is not yet clear whether it slows transmissions or spells progress toward achieving herd immunity, experts say.

The Jewish state is carrying out what is widely described as the world’s fastest vaccination campaign per capita, watched closely by experts worldwide.

While many countries are struggling with procurement, Israel has made remarkable progress since launching inoculations in December.

So far, it has given the first of the two recommended doses of Pfizer jabs to roughly 35% of its nine-million population.

About 1.8 million have also received the second jab, mostly those over 60.

The health ministry announced that beginning Thursday, all Israelis aged 16 and over would be able to set an appointment to be vaccinated, dropping the age limit from its previous minimum of 35.

In a statement, the ministry stressed Wednesday that Israel’s four health service providers should still focus their efforts on inoculating people aged 50 and over, as well as housebound Israelis.

Israel secured its substantial stock by paying above market price and by striking a data-sharing deal with Pfizer.

The agreement stipulates that Israel, which has one of the world’s most sophisticated medical data systems, will share real-time information with Pfizer on the vaccine’s impact, including on progress towards herd immunity.

Direct vs indirect protection

Ran Balicer, chairman of Israel’s national expert panel on Covid-19, told AFP it was crucial to distinguish between the vaccine’s two impacts.

The first is “the direct effect”, of vaccinated people becoming “protected against symptomatic illness and severe disease”, he said.

The second, “indirect effect” refers to the vaccine providing enough immunity to enough people that it forms an “epidemiological barrier” against transmission, he said.

Balicer, also the chief innovation officer at Clalit, Israel’s largest health maintenance organisation (HMO), said the data shows the vaccine reduces serious illness, but the transmission question remained open.

Gabi Barbash, a prominent public health expert currently with the Weizmann Institute of Science, agreed.

“We do know that vaccines are decreasing the incidence of severe disease. That’s it,” he told AFP.

“We do not know whether the vaccines are minimising transmission.”

Phase IV

In November, Pfizer announced that Phase III trials had showed its vaccine was 95% effective against the virus.

Given the gravity of the pandemic, it received regulatory approval through an accelerated trial process, which has made Israel’s more comprehensive data even more valuable.

The country’s Maccabi Institute of Innovation and Research, linked to a HMO of the same name, published a paper this week that it described as “the first and largest Phase IV study on the effectiveness of the (Pfizer-BioNTech) vaccine”.

Clalit and Maccabi are two of Israel’s four HMOs, which collectively provide healthcare to the entire population.

The HMOs are directly responsible for vaccinations and collecting data on their impact.

Maccabi compared the incidence of Covid-19 in the 12 days after individuals receiving their first Pfizer shot against incidence 13 to 24 days after the jab.

It found a 51% reduction in the incidence of lab confirmed infections in the latter period.

“Two weeks after the first dose you see a significant reduction in infection but it is not complete,” Gabriel Chodick, co-author of the Maccabi report, told AFP.

Moreover, Israel is only testing those who present coronavirus symptoms, not a randomised sample of the entire vaccinated population.

It does not therefore have comprehensive data on the number of vaccinated people carrying the virus without symptoms.

Two jabs

Pfizer recommends administering its vaccine in two doses, three weeks apart.

Israel has enough stocks to follow these recommendations, meaning it does not have data on whether the protective effect from just one jab increases after 24 days in the absence of a second jab.

Maccabi has also released preliminary data on the second jab’s impact.

It showed that out of 248,000 people studied one week after receiving their second injection, only 66 mild coronavirus infections were registered.

While those figures point towards near-total protection, Maccabi has stressed this data has not been fully analysed.

Despite its vaccination campaign, Israel has continued to register daily caseloads above 5,000, despite a nationwide lockdown in place since Dec 27.

But compliance with and enforcement of the lockdown has been uneven, notably among ultra-Orthodox Jews who have persistently flouted public safety rules throughout the pandemic.

“If you look at the number of new identified positive corona cases per day, it has not decreased for the last month and half,” Barbash said.

“So is it because the lockdown is not a (real) lockdown, or is it because the vaccine is not minimising transmission? No one can tell that.”

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Daily cases back over 2,000, death toll up by 11

2,253 new cases, 3,085 recoveries.

Maximum RM10,000 fine for SOP offenders beginning March 11

Companies or corporations that violate the SOPs can be fined up to RM50,000.

China approves 2 more home-grown Covid-19 vaccines for use

China is exporting vaccines to 27 countries and providing free doses to 53 others, a foreign ministry spokesman says.

US approves Pfizer vaccine storage at normal freezer temperature

The move loosens a previous requirement that the vaccine should be stored at ultra-low temperatures, between -80 to -60 degrees Celsius.

It’s not just about patent rights, expert says on ways to make Covid jabs cheaper

India's Serum Institute offers a good example of overcoming the problem of vaccine exclusivity during the current health emergency.